GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 421 filers reported holding GUARDANT HEALTH INC in Q1 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $375,539 | -93.8% | 12,670 | -95.1% | 0.00% | -96.0% |
| Q1 2023 | $6,095,220 | +815.2% | 260,035 | +2001.1% | 0.02% | +733.3% |
| Q3 2022 | $666,000 | -88.8% | 12,376 | -91.6% | 0.00% | -90.9% |
| Q2 2022 | $5,967,000 | +1287.7% | 147,925 | +3340.1% | 0.03% | +3200.0% |
| Q4 2021 | $430,000 | -20.1% | 4,300 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $538,000 | -82.0% | 4,300 | -82.2% | 0.00% | -81.8% |
| Q2 2021 | $2,993,000 | -62.5% | 24,100 | -53.9% | 0.01% | -76.6% |
| Q1 2021 | $7,972,000 | +1055.4% | 52,223 | +875.4% | 0.05% | +840.0% |
| Q4 2020 | $690,000 | -77.4% | 5,354 | -80.4% | 0.01% | -87.8% |
| Q3 2020 | $3,057,000 | +202.1% | 27,348 | +119.3% | 0.04% | +156.2% |
| Q2 2020 | $1,012,000 | -15.5% | 12,468 | -33.5% | 0.02% | +45.5% |
| Q3 2019 | $1,197,000 | +259.5% | 18,751 | +386.0% | 0.01% | +266.7% |
| Q2 2019 | $333,000 | – | 3,858 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |